Skinvisible Pharmaceuticals Enters Into Feasibility Study With Major Pharmaceutical Company
February 01, 2011 09:10 ET
|
Skinvisible, Inc.
LAS VEGAS, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Skinvisible Pharmaceuticals, Inc. (OTCBB:SKVI) and (OTCQB:SKVI) has entered into a feasibility agreement with Novartis Pharma AG. Under the agreement...
Skinvisible Enters US License Agreement for New Prescription Product
December 14, 2010 09:05 ET
|
Skinvisible, Inc.
LAS VEGAS, Dec. 14, 2010 (GLOBE NEWSWIRE) -- Further to its press release of April 13, 2010, Skinvisible, Inc. (OTCBB:SKVI) is pleased to announce it has entered into an exclusive licensing...
Skinvisible's Invisicare Patent Portfolio Strengthens
July 27, 2010 09:05 ET
|
Skinvisible, Inc.
LAS VEGAS, July 27, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI) announced today the Hong Kong Patent Office has issued the Company a patent (No. HK1066971) covering its unique polymer...
Skinvisible Granted Patent for South Korea
March 23, 2010 09:05 ET
|
Skinvisible, Inc.
LAS VEGAS, March 23, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI) announced today that the South Korean patent office has granted a patent for Invisicare®, the company's polymer...
Skinvisible Licensee Receives Reorder from Walgreens
January 28, 2010 09:05 ET
|
Skinvisible, Inc.
LAS VEGAS, Jan. 28, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc.’s (OTCBB:SKVI) licensee, JD Nelson and Associates LLC, announced today that reorders have been received as a result of the...